Home › Glioma › Florida › Jacksonville
Glioma clinical trials in Jacksonville, FL
6 studies for Glioma are looking for participants at sites in and around Jacksonville (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
000860: A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations
RecruitingPhase 1/2
- Mayo Clinic Flordia, Jacksonville
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
RecruitingPhase 1/2
- Mayo Clinic Jacksonville, Jacksonville
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- Mayo Clinic - Florida, Jacksonville
Preoperative Radiosurgery for the Treatment of High Grade Glioma, NeoGlioma Trial
RecruitingPhase 1
- Mayo Clinic in Florida, Jacksonville
A Digital Treatment Platform for the Delivery of Home-Based Sequential Therapy in Patients With Glioma, GHoST Trial
Recruiting
- Mayo Clinic in Florida, Jacksonville
Safety and Efficacy Study of TX103 CAR-T Cell Therapy for Recurrent or Progressive Grade 4 Glioma.
RecruitingPhase 1
- Mayo Clinic in Florida, Jacksonville
Glioma trials in other cities
- New York City, NY26 studies
- Houston, TX24 studies
- Boston, MA19 studies
- Washington, DC17 studies
- Philadelphia, PA15 studies
- Columbus, OH15 studies
- San Francisco, CA15 studies
- Miami, FL15 studies
- Durham, NC12 studies
- Chicago, IL12 studies
- Los Angeles, CA11 studies
- Aurora, CO10 studies
Other studies in Jacksonville
- Non-Small Cell Lung Cancer41 studies
- Breast Cancer38 studies
- Cancer (all types)29 studies
- Metastatic Cancer27 studies
- Colorectal Cancer25 studies
- Prostate Cancer25 studies
- Obesity25 studies
- Pancreatic Cancer21 studies
- Heart Failure20 studies
- Overweight19 studies
- Multiple Myeloma19 studies
- Lung Cancer18 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.